Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges.
Ao HuangJia-Feng ChenJian-Zhang WuZheng GaoYing-Hong ShiXiu-Tao FuXin ZhangWei-Ren LiuQiang GaoHui-Chuan SunGuo-Ming ShiJia FanZhen-Bin DingJian ZhouPublished in: Journal of oncology (2022)
Avatrombopag was safe and effective and ensured successful implementation of anticancer treatment in liver cancer patients with severe thrombocytopenia, accompanied with or without CLD.